Ascendis Pharma A (ASND) Treasury Shares (2025 - 2026)
Ascendis Pharma A (ASND) reported Treasury Shares of -$60.7 million for Q1 2026, down 231.78% on a YoY basis from $46.1 million in Q1 2025, and down 231.78% sequentially from -$18.3 million in Q1 2025.
Ascendis Pharma A (ASND) Treasury Shares (2025 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 2 years of Treasury Shares data on file, last reported at -$60.7 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | -60.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.71 Mn |
| Mar 31, 2026 | -60.71 Mn |
| Mar 31, 2025 | -18.30 Mn |
| Mar 31, 2025 | -18.30 Mn |